India’s Deal Street Revs Up Targeting Brands, Medical Devices, Contract Manufacturing

While the overall Indian pharmaceutical market is seeing early signs of a rebound after a dull 2013, interest is steadily building for buyout targets like high yield brands, medical devices and companies that bring expertise to manufacturing.

MUMBAI – India’s deal street looks set for brisk activity this year across biomedical-related firms. Investment bankers see high interest in large health care-related brands outside of price controls launched last year, as well as medical devices priced for the middle class and contract manufacturing operations.

All of these areas are seen by strategic and financial investors as an opportunity to catch the next leg of...

Welcome to HBW Insight

Create an account to read this article

More from Asia

Eisai Switches Proton Pump Inhibitor Rabeprazole To OTC In Japan

 
• By 

Eisai aims to support people in Japan with severe heartburn and discomfort caused by gastric acid related conditions by switching from prescription to OTC status its Pariet-branded proton pump inhibitor.

Thai TikTok Boom Driving Double-Digit Growth In Southeast Asia’s Dietary Supplements Market

 
• By 

TikTok dietary supplement sales in Thailand grew by an astonishing 635% in 2024, while sales via Vietnam's and Malaysia's traditional e-commerce platforms increased by a still impressive 73% and 83% respectively.

Haleon Completes Deal To Grow Stake In China JV

 
• By 

Haleon now holds 88% of its China OTC joint venture after acquiring a larger stake in the business from its local partners.

APAC Congress: Regulators And Industry Agree ‘Bangkok Joint Initiative on Self-Care’

 
• By 

Organizations representing APAC health and medicines regulators and the consumer health industry respectively have agreed to “recognize the importance of self-care as a fundamental pillar of health and wellbeing” and “affirm our dedication to advancing self-care as an essential component of Universal Health Coverage.”

More from Geography

Haleon Adds High Strength Vitamin D To UK Centrum Multivitamin Line

 
• By 

Centrum Vitamin D Boost combines a wide range of daily vitamins with a 30-microgram dose of vitamin D, delivering six times more of the micronutrient than the firm’s Centrum Advance.

Self-Testing Kits Need To Be Regulated Like OTCs, UK Researchers Argue

 
• By 

Concerns raised by two recent studies prompt UK researchers to argue for greater regulation with regards to direct-to-consumer test kits.

Urban Wastewater Directive: AESGP Requests Intervention In EFPIA’s Legal Action

 
• By 

AESGP has formally submitted a request to the General Court of the European Union to intervene in the European Federation of Pharmaceutical Industries and Association’s legal action against the revised EU Urban Wastewater Directive.